Molecular interactions of the IGF system

被引：322

作者：

Denley, A

Cosgrove, LJ

Booker, GW

Wallace, JC

Forbes, BE ^{[1
]}

机构：

[1] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia

[2] CSIRO, Div Hlth Sci & Nutr, Adelaide, SA, Australia

来源：

CYTOKINE & GROWTH FACTOR REVIEWS | 2005年 / 16卷 / 4-5期

关键词：

insulin-like growth factor; IGF receptors; IGFBP; structure; function;

D O I：

10.1016/j.cytogfr.2005.04.004

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The insulin-like growth factor (IGF) system is a complex network of two soluble ligands; several cell surface transmembrane receptors and six soluble high-affinity binding-proteins. The IGF system is essential for normal embryonic and postnatal growth, and plays an important role in the function of a healthy immune system, lymphopoiesis, myogenesis and bone growth among other physiological functions. Deregulation of the IGF system leads to stimulation of cancer cell growth and survival. In order to manipulate the IGF system in the treatment of certain disorders, we must understand the protein-protein interactions at a molecular level. The complex molecular interactions of the ligands and receptors of the IGF system underlie all the biological actions mentioned above and will be the focus of this review. (C) 2005 Elsevier Ltd. All rights reserved.

引用

收藏

页码：421 / 439

页数：19

相关论文

共 124 条

[31] A GROWTH-DEFICIENCY PHENOTYPE IN HETEROZYGOUS MICE CARRYING AN INSULIN-LIKE GROWTH FACTOR-II GENE DISRUPTED BY TARGETING [J].

DECHIARA, TM ;

EFSTRATIADIS, A ;

ROBERTSON, EJ .

NATURE, 1990, 345 (6270) :78-80

[32] THE STRUCTURAL BASIS OF INSULIN AND INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR-BINDING AND NEGATIVE COOPERATIVITY, AND ITS RELEVANCE TO MITOGENIC VERSUS METABOLIC SIGNALING [J].

DEMEYTS, P .

DIABETOLOGIA, 1994, 37 :S135-S148

[33] Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR [J].

Denley, A ;

Bonython, ER ;

Booker, GW ;

Cosgrove, LJ ;

Forbes, BE ;

Ward, CW ;

Wallace, JC .

MOLECULAR ENDOCRINOLOGY, 2004, 18 (10) :2502-2512

[34] Structural and functional characteristics of the Val44Met insulin-like growth factor I missense mutation:: Correlation with effects on growth and development [J].

Denley, A ;

Wang, CXC ;

McNeil, KA ;

Walenkamp, MJE ;

van Duyvenvoorde, H ;

Wit, JM ;

Wallace, JC ;

Norton, RS ;

Karperien, M ;

Forbes, BE .

MOLECULAR ENDOCRINOLOGY, 2005, 19 (03) :711-721

[35]

Denley A, 2003, HORM METAB RES, V35, P778

[36] M6P/IGF2R GENE IS MUTATED IN HUMAN HEPATOCELLULAR CARCINOMAS WITH LOSS OF HETEROZYGOSITY [J].

DESOUZA, AT ;

HANKINS, GR ;

WASHINGTON, MK ;

ORTON, TC ;

JIRTLE, RL .

NATURE GENETICS, 1995, 11 (04) :447-449

[37] An insulin-like growth factor II (IGF-II) affinity-enhancing domain localized within extracytoplasmic repeat 13 of the IGF-II/mannose 6-phosphate receptor [J].

Devi, GR ;

Byrd, JC ;

Slentz, DH ;

MacDonald, RG .

MOLECULAR ENDOCRINOLOGY, 1998, 12 (11) :1661-1672

[38]

DeWolf E, 1996, PROTEIN SCI, V5, P2193

[39] Binding protein-3-selective insulin-like growth factor I variants:: Engineering, biodistributions, and clearance [J].

Dubaquié, Y ;

Mortensen, DL ;

Intintoli, A ;

Hogue, DA ;

Nakamura, G ;

Rancatore, P ;

Lester, P ;

Sadick, MD ;

Filvaroff, E ;

Fielder, PJ ;

Lowman, HB .

ENDOCRINOLOGY, 2001, 142 (01) :165-173

[40] Total alanine-scanning mutagenesis of insulin-like growth factor I (IGF-I) identifies differential binding epitopes for IGFBP-1 and IGFBP-3 [J].

Dubaquié, Y ;

Lowman, HB .

BIOCHEMISTRY, 1999, 38 (20) :6386-6396

← 1 2 3 4 5 6 7 8 9 10 →